Homburger provided legal counsel to Commerzbank Aktiengesellschaft for a syndicated corporate financing deal involving Montana Aerospace. This company is a well-known manufacturer of aerospace system components and complex assemblies, operating globally with development and production
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
Bär & Karrer announced the opening of a new office in St. Moritz. This expansion highlights the law firm commitment to providing tailored legal and tax advice to private clients and businesses. Acknowledging the
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
Following its spin-off from Novartis on 4 October 2023, Sandoz, a global leader in the generics and biosimilars markets with one of the broadest port
Kellerhals Carrard has partnership with Logol, an innovative Swiss technology solutions provider and pioneer in AI-driven legal solutions. This collaboration marks a significant milestone in the legal sector as Kellerhals Carrard becomes the first law
Pregnolia, a femtech startup, has raised CHF 2.2 million in another round of financing. The company has developed a device for measuring cervical stiffness in pregnant women, an important parameter in predicting spontaneous premature births. The
Partners Group, a renowned global private markets firm, acting on behalf of its clients, has agreed to acquire ROSEN Group, a global provider of mission-critical inspection services for energy infrastructure assets, from its founder, Hermann
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned
